关于叶酸可接受的上限摄入量水平的科学意见
EFSA journal. European Food Safety Authority
|November 15, 2023
概括
对叶酸的可容忍上限摄入量 (UL) 进行了修订,保留了以前的安全限值. 在科巴拉明缺乏个体的神经症状的风险是建立这些ULs的关键因素.
科学领域:
- 营养科学 营养科学
- 食品安全 食品安全
- 公共卫生 公共卫生
背景情况:
- 欧盟委员会要求对叶酸及其相关化合物的可容忍上限摄入量 (UL) 进行修订.
- 人们担心过多摄入叶酸会对健康产生潜在的不良影响,包括神经问题和癌症风险.
研究的目的:
- 关于对叶酸和其他叶酸形式的 UL 修订进行科学意见.
- 评估与高叶酸摄入量相关的不良健康影响的证据.
主要方法:
- 进行了系统的文献审查,以评估有关优先有害健康影响的证据.
- 特别关注的是可巴胺依赖性神经病变,低可巴胺状态的认知衰退以及结直肠和前列腺癌的风险.
主要成果:
- 证据不足以确定叶酸摄入量与认知功能受损,结肠直肠癌或前列腺癌之间的因果关系.
- 在科巴拉明缺乏症患者中,神经症状的进展被确定为UL建立的关键影响.
- 在所有人群中保留了叶酸的现有UL,在4至11个月的婴儿中,新的UL为200μg/天.
结论:
- 叶酸和相关化合物的确定的ULs被认为是对欧洲一般人口的保护.
- 过量摄入不太可能,除了经常服用高剂量叶酸补充剂的人外.
- 在科巴胺缺乏症下神经症状进展的风险仍然是叶酸ULs的关键考虑因素.
相关概念视频
Bioavailability: Overview
2.8K
Bioavailability refers to the proportion of an unaltered drug that, after administration, enters the systemic circulation and can be distributed to the desired action site. Factors such as gastrointestinal (GI) absorption and liver biotransformation influence the bioavailability of a drug when it is administered orally. When a drug is administered intravenously, it enters the systemic circulation directly; by definition, its bioavailability is assumed to be 100%. The bioavailability of an...
2.8K
Factors Influencing Bioavailability: First-Pass Elimination
6.4K
When a drug is taken orally, it undergoes a journey starting from the gastrointestinal (GI) tract, passing through the portal vein, reaching the liver, and finally entering the systemic circulation. This process involves the absorption of the drug across the GI tract. The liver is the primary site for metabolizing the drug, with some metabolism also occurring in the gut wall. This journey significantly reduces the quantity of the drug that reaches the systemic circulation, a phenomenon known as...
6.4K
Teratogenicity
2.5K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Lipids: Dietary Sources and Requirements
765
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
765
Therapeutic Index
4.3K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
4.3K


